Connor, Clark & Lunn Investment Management (CC&L)’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $466K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $409K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $828K | Buy |
|
|||||
|
2023
Q1 | $560K | Sell |
|
|||||
|
2022
Q4 | $1.31M | Sell |
|
|||||
|
2022
Q3 | $1.71M | Buy |
|
|||||
|
2022
Q2 | $210K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $795K | Buy |
|